Immune defence against Candida fungal infections

Nature Reviews Immunology

Volumn 15, Issue 10, 2015, Pages 630-642

  Netea, Mihai G ^a   Joosten, Leo A B ^a   Van Der Meer, Jos W M ^a   Kullberg, Bart Jan ^a   Van De Veerdonk, Frank L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; BETA DEFENSIN; BETA GLUCAN; CALGRANULIN; CASPASE 8; CASPASE RECRUITMENT DOMAIN PROTEIN 15; DECTIN 1; ELASTASE; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 22; INTERLEUKIN 6; MANNAN; MANNOPROTEIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PERFORIN; PROTEIN KINASE C DELTA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; CYTOKINE;

ADAPTIVE IMMUNITY; ANTIFUNGAL ACTIVITY; ANTIGEN RECOGNITION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA MENINGITIS; CANDIDIASIS; CHRONIC GRANULOMATOUS DISEASE; COMMENSAL; CYTOKINE PRODUCTION; ENDOCYTOSIS; EPITHELIUM CELL; EXTRACELLULAR TRAP; FUNCTIONAL GENOMICS; FUNGAL COLONIZATION; FUNGUS HYPHAE; GENETIC ASSOCIATION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; INNATE IMMUNITY; INVASIVE CANDIDIASIS; LOSS OF FUNCTION MUTATION; LYMPH NODE; LYMPHOID CELL; MACROPHAGE; MEDIATOR RELEASE; MONOCYTE; NATURAL KILLER CELL; NEUTROPENIA; NEUTROPHIL; NONHUMAN; OLIGOMERIZATION; PHAGOLYSOSOME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPECIES; YEAST; BIOLOGICAL MODEL; CYTOLOGY; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ADAPTIVE IMMUNITY; CANDIDA; CANDIDIASIS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; RECEPTORS, PATTERN RECOGNITION;

EID: 84942829247     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3897     Document Type: Review

References (189)

1. Brown G. D., Denning D. W., & Levitz S. M. Tackling human fungal infections. Science 336, 647 (2012
2. Gudlaugsson O., et al. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37, 1172-1177 (2003
3. Wisplinghoff H., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309-317 (2004
4. Shibata N., Suzuki A., Kobayashi H., & Okawa Y. Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms. Biochem. J. 404, 365-372 (2007
5. Lowman D. W., et al. Novel structural features in Candida albicans hyphal glucan provide a basis for differential innate immune recognition of hyphae versus yeast. J. Biol. Chem. 289, 3432-3443 (2014
6. Munro C. A., Schofield D. A., Gooday G. W., & Gow N. A. Regulation of chitin synthesis during dimorphic growth of Candida albicans. Microbiol. 144, 391-401 (1998
7. Naglik J. Candida immunity. New J. Sci. 1, 1-27 (2014
8. Davis S. E., et al. Masking of β(1 3)-glucan in the cell wall of Candida albicans from detection by innate immune cells depends on phosphatidylserine. Infect. Immun. 82, 4405-4413 (2014
9. Brown G. D., & Gordon S. Immune recognition. A new receptor for β-glucans. Nature 413, 36-37 (2001
10. Goodridge H. S., et al. Activation of the innate immune receptor Dectin 1 upon formation of a 'phagocytic synapse'. Nature 472, 471-475 (2011
11. Brown G. D., et al. Dectin 1 is a major β-glucan receptor on macrophages. J. Exp. Med.196, 407-412 (2002
12. Whitney P. G., et al. Syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection. PLoS Pathog. 10, e1004276 (2014
13. Bishu S., et al. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. Infect. Immun. 82, 1173-1180 (2014
14. Gross O., et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651-656 (2006
15. Glocker E. O., et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med.361, 1727-1735 (2009
16. Strasser D., et al. Syk kinase-coupled C type lectin receptors engage protein kinase C s to elicit Card9 adaptor-mediated innate immunity. Immunity 36, 32-42 (2012
17. Gringhuis S. I., et al. Dectin 1 directs T helper cell differentiation by controlling noncanonical NF κB activation through Raf 1 and Syk. Nat. Immunol. 10, 203-213 (2009
18. Brown G. D., et al. Dectin 1 mediates the biological effects of β-glucans. J. Exp. Med. 197, 1119-1124 (2003
19. Ferwerda G., Meyer-Wentrup F., Kullberg B. J., Netea M. G., & Adema G. J. Dectin 1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell. Microbiol. 10, 2058-2066 (2008
20. Gantner B. N., Simmons R. M., Canavera S. J., Akira S., & Underhill D. M. Collaborative induction of inflammatory responses by dectin 1 and Toll-like receptor 2. J. Exp. Med. 197, 1107-1117 (2003
21. Branzk N., et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat. Immunol. 5, 1017-1025 (2014
22. Marakalala M. J., et al. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin 1. PLoS Pathog. 9, e1003315 (2013
23. Cunha C., Aversa F., Romani L., & Carvalho A. Human genetic susceptibility to invasive aspergillosis. PLoS Pathog. 9, e1003434 (2013
24. Smeekens S. P., Van De Veerdonk F. L., Kullberg B. J., & Netea M. G. Genetic susceptibility to Candida infections. EMBO Mol. Med. 5, 805-813 (2013
25. Ferwerda B., et al. Human dectin 1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361, 1760-1767 (2009
26. De Luca A., et al. IL 22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLoS Pathog. 9, e1003486 (2013
27. Drewniak A., et al. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121, 2385-2392 (2013
28. Drummond R. A., Saijo S., Iwakura Y., & Brown G. D. The role of Syk/CARD9 coupled C type lectins in antifungal immunity. Eur. J. Immunol. 41, 276-281 (2011
29. Van Bruggen R., et al. Complement receptor 3, not Dectin 1, is the major receptor on human neutrophils for β-glucan-bearing particles. Mol. Immunol. 47, 575-581 (2009
30. Gazendam R. P., et al. Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. Blood 124, 590-597 (2014
31. Smeekens S. P., et al. An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin 1 receptor antagonist via a Dectin 1/CR3 independent mechanism. Cytokine 71, 215-222 (2015
32. Hall R. A., et al. The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans. PLoS Pathogens 9, e1003276 (2013
33. Cambi A., et al. Dendritic cell interaction with Candida albicans critically depends on N linked mannan. J. Biol. Chem. 283, 20590-20599 (2008
34. Saijo S., et al. Dectin 2 recognition of α-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32, 681-691 (2010
35. Van De Veerdonk F. L., et al. The macrophage mannose receptor induces IL 17 in response to Candida albicans. Cell Host Microbe 5, 329-340 (2009
36. Yamasaki S., et al. C type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc. Natl Acad. Sci. USA 106, 1897-1902 (2009
37. Netea M. G., Brown G. D., Kullberg B. J., & Gow N. A. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 6, 67-78 (2008
38. Ifrim D. C., et al. Role of Dectin 2 for host defense against systemic infection with Candida glabrata. Infect. Immun. 82, 1064-1073 (2014
39. Zhu L. L., et al. C type lectin receptors Dectin 3 and Dectin 2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity 39, 324-334 (2013
40. Jouault T., et al. Specific recognition of Candida albicans by macrophages requires galectin 3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J. Immunol. 177, 4679-4687 (2006
41. Linden J. R., De Paepe M. E., Laforce-Nesbitt S. S., & Bliss J. M. Galectin 3 plays an important role in protection against disseminated candidiasis. Med. Mycol. 51, 641-651 (2013
42. Wells C. A., et al. The macrophage-inducible C type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J. Immunol. 180, 7404-7413 (2008
43. Saevarsdottir S., Vikingsdottir T., & Valdimarsson H. The potential role of mannan-binding lectin in the clearance of self-components including immune complexes. Scand. J. Immunol. 60, 23-29 (2004
44. Means T. K., et al. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206, 637-653 (2009
45. Nahum A., Dadi H., Bates A., & Roifman C. M. The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity. J. Allergy Clin. Immunol. 127, 528-531 (2011
46. Wagener J., et al. Fungal chitin dampens inflammation through IL 10 induction mediated by NOD2 and TLR9 activation. PLoS Pathog. 10, e1004050 (2014
47. Kato H., et al. Differential roles of MDA5 and RIG I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006
48. Jaeger M., et al. The RIG I like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infections. Eur. J. Clin. Immunol. Infect. Dis. 34, 963-974 (2015
49. Agostini L., et al. NALP3 forms an IL 1β processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325 (2004
50. Gross O., et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459, 433-436 (2009
51. Hise A. G., et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5, 487-497 (2009
52. Joly S., et al. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J. Immunol. 183, 3578-3581 (2009
53. Gow N. A., Van De Veerdonk F. L., Brown A. J., & Netea M. G. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat. Rev. Microbiol. 10, 112-122 (2012
54. Cheng S. C., et al. The dectin 1/inflammasome pathway is responsible for the induction of protective T helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J. Leuk. Biol. 90, 357-366 (2011
55. Pietrella D., et al. Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. Eur. J. Immunol. 43, 679-692 (2013
56. Robinson M. J., et al. Dectin 2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J. Exp. Med. 206, 2037-2051 (2009
57. Gringhuis S. I., et al. Dectin 1 is an extracellular pathogen sensor for the induction and processing of IL 1β via a noncanonical caspase 8 inflammasome. Nat. Immunol. 13, 246-254 (2012
58. Ganesan S., et al. Caspase 8 modulates dectin 1 and complement receptor 3 driven IL 1β production in response to β-glucans and the fungal pathogen, Candida albicans. J. Immunol. 193, 2519-2530 (2014
59. Wellington M., Koselny K., Sutterwala F. S., & Krysan D. J. Candida albicans triggers NLRP3 mediated pyroptosis in macrophages. Eukar. Cell. 13, 329-340 (2014
60. Uwamahoro N., et al. The pathogen Candida albicans hijacks pyroptosis for escape from macrophages. mBio 5, e00003-e00014 (2014
61. Tomalka J., et al. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathogens 7, e1002379 (2011
62. Netea M. G., et al. Differential requirement for the activation of the inflammasome for processing and release of IL 1β in monocytes and macrophages. Blood 113, 2324-2335 (2009
63. Van De Veerdonk F. L., et al. Bypassing pathogen-induced inflammasome activation for the regulation of interleukin 1β production by the fungal pathogen Candida albicans. J. Infect. Dis. 199, 1087-1096 (2009
64. Dinarello C. A. Interleukin 1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720-3732 (2011
65. Netea M. G., Van De Veerdonk F. L., Van Der Meer J. W., Dinarello C. A., & Joosten L. A. Inflammasome-independent regulation of IL 1 family cytokines. Annu. Rev. Immunol. 33, 49-77 (2014
66. Kullberg B. J., Van 't Wout J. W., & Van Furth R. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin 1. Infect. Immun. 58, 3319-3324 (1990
67. Vonk A. G., Netea M. G., Van Der Meer J. W., & Kullberg B. J. Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy. Exp. Opin. Biol. Ther. 6, 891-903 (2006
68. Mencacci A., et al. Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1 deficient mice. Infect. Immun. 68, 5126-5131 (2000
69. Beausejour A., Grenier D., Goulet J. P., & Deslauriers N. Proteolytic activation of the interleukin 1β precursor by Candida albicans. Infect. Immun. 66, 676-681 (1998
70. Gow N. A., Brown A. J., & Odds F. C. Fungal morphogenesis and host invasion. Curr. Opin. Microbiol.5, 366-371 (2002
71. d'Ostiani C. F., et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191, 1661-1674 (2000
72. Van Der Graaf C. A., Netea M. G., Verschueren I., Van Der Meer J. W., & Kullberg B. J. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infec. Immun. 73, 7458-7464 (2005
73. Gantner B. N., Simmons R. M., & Underhill D. M. Dectin 1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24, 1277-1286 (2005
74. Brunke S., & Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell. Microbiol. 15, 701-708 (2013
75. Weindl G., et al. Human epithelial cells establish direct antifungal defense through TLR4 mediated signaling. J. Clin. Invest.117, 3664-3672 (2007
76. Moyes D. L., et al. A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe 8, 225-235 (2010
77. Moyes D. L., et al. Candida albicans yeast and hyphae are discriminated by MAPK signaling in vaginal epithelial cells. PLoS ONE 6, e26580 (2011
78. Eyerich S., et al. IL 22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur. J. Immunol. 41, 1894-1901 (2011
79. Tomalka J., et al. β-defensin 1 plays a role in acute mucosal defense against Candida albicans. J. Immunol. 194, 1788-1795 (2015
80. Qian Q., Jutila M. A., Van Rooijen, & N., & Cutler J. E. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152, 5000-5008 (1994
81. Ngo L. Y., et al. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J. Infect. Dis. 209, 109-119 (2014
82. Lionakis M. S., et al. CX3CR1 dependent renal macrophage survival promotes Candida control and host survival. J. Cin. Invest. 123, 5035-5051 (2013
83. Break T. J., et al. CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans. Infect. Immun. 83, 958-965 (2015
84. Smeekens S. P., et al. The classical CD14++ CD16- monocytes, but not the patrolling CD14+ CD16+ monocytes, promote Th17 responses to Candida albicans. Eur. J. Immunol. 41, 2915-2924 (2011
85. Horn D. L., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48, 1695-1703 (2009
86. Uzun O., Ascioglu S., Anaissie E. J., & Rex J. H. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clin. Infect. Dis. 32, 1713-1707 (2001
87. Brown G. D. Innate antifungal immunity: the key role of phagocytes. Annu. Rev. Immunol. 29, 1 (2011
88. Aratani Y., et al. Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. J. Infect. Dis. 185, 1833-1837 (2002
89. Lehrer R. I. Measurement of candidacidal activity of specific leukocyte types in mixed cell populations I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils. Infect. Immun. 2, 42-47 (1970
90. Lehrer R. I., & Cline M. J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J. Cin. Invest. 48, 1478-1488 (1969
91. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J. Mol. Med. 76, 676-681 (1998
92. Amulic B., Cazalet C., Hayes G. L., Metzler K. D., & Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30, 459-489 (2012
93. McCormick A., et al. NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect. 12, 928-936 (2010
94. Menegazzi R., Decleva E., & Dri P. Killing by neutrophil extracellular traps: fact or folkloré. Blood 119, 1214-1216 (2012
95. Urban C. F., et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathogens 5, e1000639 (2009
96. Sorensen O. E., et al. Human cathelicidin, hCAP 18, is processed to the antimicrobial peptide LL 37 by extracellular cleavage with proteinase 3. Blood 97, 3951-3959 (2001
97. Kahlenberg J. M., & Kaplan M. J. Little peptide, big effects: the role of LL 37 in inflammation and autoimmune disease. J. Immunol. 191, 4895-4901 (2013
98. Zhang X., et al. Dual functions of the human antimicrobial peptide LL 37 target membrane perturbation and host cell cargo delivery. Biochim. Biophys. Acta 1798, 2201-2208 (2010
99. Tsai P. W., Yang C. Y., Chang H. T., & Lan C. Y. Human antimicrobial peptide LL 37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE 6, e17755 (2011
100. Alalwani S. M., et al. The antimicrobial peptide LL 37 modulates the inflammatory and host defense response of human neutrophils. Eur. J. Immunol. 40, 1118-1126 (2010
101. Nagaoka I., Tamura H., & Hirata M. An antimicrobial cathelicidin peptide, human CAP18/LL 37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol. 176, 3044-3052 (2006
102. Kaloriti D., et al. Mechanisms underlying the exquisite sensitivity of Candida albicans to combinatorial cationic and oxidative stress that enhances the potent fungicidal activity of phagocytes. mBio 5, e01334 (2014
103. Nicola A. M., et al. Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Infect. Immun. 80, 3065-3076 (2012
104. Rosentul D. C., et al. Role of autophagy genetic variants for the risk of Candida infections. Med. Mycol. 52, 333-341 (2014
105. Smeekens S. P., et al. Autophagy is redundant for the host defense against systemic Candida albicans infections. Eur. J. Clin. Microbiol. Infect. Dis. 33, 711-722 (2014
106. Wirnsberger G., et al. Jagunal homolog 1 is a critical regulator of neutrophil function in fungal host defense. Nat. Genet. 46, 1028-1033 (2014
107. Romani L., et al. Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice. Infect. Immun. 61, 3769-3774 (1993
108. Quintin J., et al. Differential role of NK cells against Candida albicans infection in immunocompetent or immunocompromised mice. Eur. J. Immunol. 44, 2405-2414 (2014
109. Voigt J., et al. Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity. J. Infect. Dis. 209, 616-626 (2014
110. Biondo C., et al. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. Eur. J. Immunol. 41, 1969-1979 (2011
111. del Fresno C., et al. Interferon-β production via Dectin 1-Syk- IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38, 1176-1186 (2013
112. Bourgeois C., et al. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7 mediated IFN-β signaling. J. Immunol.186, 3104-3112 (2011
113. Netea M. G., et al. Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages. Microb. Infect. 6, 985-989 (2004
114. Zielinski C. E., et al. Pathogen-induced human TH17 cells produce IFN-γ or IL 10 and are regulated by IL β. Nature 484, 514-518 (2012
115. Shalaby M. R., et al. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J. Immunol. 135, 2069-2073 (1985
116. Nathan C. F., Murray H. W., Wiebe M. E., & Rubin B. Y. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670-689 (1983
117. Netea M. G., et al. Differential role of IL 18 and IL 12 in the host defense against disseminated Candida albicans infection. Eur. J. Immunol. 33, 3409-3417 (2003
118. Kullberg B. J., Van 't Wout J. W., Hoogstraten C., & Van Furth R. Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis. 168, 436-443 (1993
119. Stuyt R. J., Netea M. G., Van Krieken J. H., Van Der Meer J. W., & Kullberg B. J. Recombinant interleukin 18 protects against disseminated Candida albicans infection in mice. J. Infect. Dis. 189, 1524-1527 (2004
120. Delsing C. E., et al. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect. Dis. 14, 166 (2014
121. Liang S. C., et al. Interleukin (IL)-22 and IL 17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006
122. Huang W., Na L., Fidel P. L., & Schwarzenberger P. Requirement of interleukin 17A for systemic anti- Candida albicans host defense in mice. J. Infect. Dis. 190, 624-631 (2004
123. Van De Veerdonk F. L., et al. Differential effects of IL 17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure. Shock 34, 407-411 (2010
124. Conti H. R., et al. Th17 cells and IL 17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206, 299-311 (2009
125. Milner J. D., et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452, 773-776 (2008
126. Van De Veerdonk F. L., et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med.365, 54-61 (2011
127. Liu L., et al. Gain of function human STAT1 mutations impair IL 17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med.208, 1635-1648 (2011
128. Puel A., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin 17 immunity. Science 332, 65-68 (2011
129. Yano J., et al. The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17 pathway. PLoS ONE 7, e46311 (2012
130. Holland S. M., et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357, 1608-1619 (2007
131. Langley R. G., et al. Secukinumab in plaque psoriasis - results of two phase 3 trials. N. Engl. J. Med. 371, 326-338 (2014
132. Mencacci A., et al. Defective antifungal T helper 1 (TH1) immunity in a murine model of allogeneic T cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. Blood 97, 1483-1490 (2001
133. Tavares D., Ferreira P., & Arala-Chaves M. Increased resistance to systemic candidiasis in athymic or interleukin 10 depleted mice. J. Infect. Dis. 182, 266-273 (2000
134. Vazquez-Torres A., Jones-Carson J., Wagner R. D., Warner T., & Balish E. Early resistance of interleukin 10 knockout mice to acute systemic candidiasis. Infect. Immun. 67, 670-674 (1999
135. Mencacci A., et al. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J. Exp. Med. 187, 307-317 (1998
136. Spits H., et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013
137. Gladiator A., Wangler N., Trautwein-Weidner K., & LeibundGut-Landmann S. Cutting edge: IL 17 secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol. 190, 521-525 (2013
138. Conti H. R., et al. Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections. J. Exp. Med. 211, 2075-2084 (2014
139. Cheng S. C., et al. Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs. Eur. J. Immunol. 42, 993-1004 (2012
140. Tsoni S. V., et al. Complement C3 plays an essential role in the control of opportunistic fungal infections. Infect. Immun. 77, 3679-3685 (2009
141. Mullick A., et al. Dysregulated inflammatory response to Candida albicans in a C5 deficient mouse strain. Infect. Immun. 72, 5868-5876 (2004
142. Magliani W., et al. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15, 155-158 (1997
143. Polonelli L., et al. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J. Immunol. 152, 3175-3182 (1994
144. Sandini S., et al. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. FEMS Immunol. Med. Microbiol. 62, 215-224 (2011
145. Torosantucci A., et al. Protection by anti-β-glucan antibodies is associated with restricted β 1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS ONE 4, e5392 (2009
146. Robert R., et al. Adherence of platelets to Candida species in vivo. Infect. Immun. 68, 570-576 (2000
147. Drago L., Bortolin M., Vassena C., Taschieri S., & Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol. 13, 47 (2013
148. Peters B. M., Yano J., Noverr M. C., & Fidel P. L. Jr. Candida vaginitis: when opportunism knocks, the host responds. PLoS Pathog. 10, e1003965 (2014
149. Miramon P., Kasper L., & Hube B. Thriving within the host: Candida spp. interactions with phagocytic cells. Med. Microbiol. Immunol. 202, 183-195 (2013
150. Toth R., et al. Kinetic studies of Candida parapsilosis phagocytosis by macrophages and detection of intracellular survival mechanisms. Front. Microbiol. 5, 633 (2014
151. Slesiona S., et al. Persistence versus escape: Aspergillus terreus and Aspergillus fumigatus employ different strategies during interactions with macrophages. PLoS ONE 7, e31223 (2012
152. Reales-Caldersn J. A., Aguilera-Montilla N., Corb? A. L., Molero G., & Gil C. Proteomic characterization of human proinflammatory M1 and anti-inflammatory M2 macrophages and their response to Candida albicans. Proteomics 14, 1503-1518 (2014
153. Dillon S., et al. Yeast zymosan, a stimulus for TLR2 and dectin 1, induces regulatory antigen-presenting cells and immunological tolerance. J. Cin. Invest.116, 916-928 (2006
154. Sutmuller R. P., et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116, 485-494 (2006
155. Tierney L., Kuchler K., Rizzetto L., & Cavalieri D. Systems biology of host-fungus interactions: turning complexity into simplicity. Cur. Opin. Microbiol. 15, 440-446 (2012
156. Zaas A. K., Aziz H., Lucas J., Perfect J. R., & Ginsburg G. S. Blood gene expression signatures predict invasive candidiasis. Sci. Transl. Med. 2, 21ra17 (2010
157. Tierney L., et al. An interspecies regulatory network inferred from simultaneous RNA-seq of Candida albicans invading innate immune cells. Front. Microbiol. 3, 85 (2012
158. Barker K. S., et al. Transcriptome profile of the vascular endothelial cell response to Candida albicans. J. Infect. Dis. 198, 193-202 (2008
159. Fradin C., et al. The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications. Infect. Immun. 75, 1493-1501 (2007
160. Smeekens S. P., et al. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat. Commun. 4, 1342 (2013
161. Majer O., et al. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathog. 8, e1002811 (2012
162. Moyes D. L., et al. Protection against epithelial damage during Candida albicans infection is mediated by PI3K/Akt and mammalian target of rapamycin signaling. J. Infect. Dis. 209, 1816-1826 (2014
163. Ikuta T., et al. Identification by DNA microarray of genes involved in Candida albicans-treated gingival epithelial cells. J. Oral Pathol. Med. 41, 769-778 (2012
164. Kumar V., et al. Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia. Nat. Commun.5, 4675 (2014
165. Oh J., et al. Biogeography and individuality shape function in the human skin metagenome. Nature 514, 59-64 (2014
166. Smeekens S. P., et al. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses. J. Innate Immun. 6, 253-262 (2014
167. Hogan D. A., Vik A., & Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol. Microbiol. 54, 1212-1223 (2004
168. Kennedy M. J., & Volz P. A. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect. Immun. 49, 654-663 (1985
169. Jenkinson H. F., Lala H. C., & Shepherd M. G. Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect. Immun. 58, 1429-1436 (1990
170. Findley K., et al. Topographic diversity of fungal and bacterial communities in human skin. Nature 498, 367-370 (2013
171. Huffnagle G. B., & Noverr M. C. The emerging world of the fungal microbiome. Trends Microbiol. 21, 334-341 (2013
172. Iliev I. D., et al. Interactions between commensal fungi and the C type lectin receptor Dectin 1 influence colitis. Science 336, 1314-1317 (2012
173. Zelante T., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin 22. Immunity 39, 372-385 (2013
174. Noverr M. C., & Huffnagle G. B. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. 72, 6206-6210 (2004
175. Maslowski K. M., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286 (2009
176. Trompette A., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159-166 (2014
177. Romani L., et al. The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism. Sem. Immunopathol. 37, 163-171 (2015
178. Oever J. T., & Netea M. G. The bacteriome- mycobiome interaction and antifungal host defense. Eur. J. Immunol. 44, 3182-3191 (2014
179. Kolwijck E., & Van De Veerdonk F. L. The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease. Eur. J. Immunol. 44, 3156-3165 (2014
180. Bistoni F., et al. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 51, 668-674 (1986
181. Bistoni F., et al. Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection. J. Med. Vet. Mycol. 26, 285-299 (1988
182. Netea M. G., Quintin J., & Van Der Meer J. W. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355-361 (2011
183. Saeed S., et al. Epigenetic programming of monocyte-to macrophage differentiation and trained innate immunity. Science 345, 1251086 (2014
184. Cheng S. C., et al. mTOR- and HIF 1α mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014
185. Ifrim D. C., et al. Defective trained immunity in patients with STAT1 dependent chronic mucocutaneaous candidiasis. Clin. Exp. Immunol. 181, 434-440 (2015
186. Bekkering S., et al. Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler. Thromb. Vasc. Biol. 34, 1731-1738 (2014
187. Bekkering S., Joosten L., Netea M. G., & Riksen N. P. Trained innate immunity as a mechanistic link between sepsis and atherosclerosis. Crit. Care 18, 645 (2014
188. Benn C. S., Netea M. G., Selin L. K., & Aaby P. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 34, 431-439 (2013
189. Aleem E. β-Glucans and their applications in cancer therapy: focus on human studies. Anticancer Agents Med. Chem. 13, 709-719 (2013